Registry and biobank for infectious diseases
Prospective Registry and Biobank of Patients With Infectious Diseases
This study is creating a database and collection of samples from patients with different infectious diseases to see how these illnesses affect treatment outcomes and to learn more about managing them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 1 site (Milan) |
| Trial ID | NCT06418048 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a comprehensive registry and biobank for patients with various infectious diseases, including bloodstream infections, central nervous system infections, and more. It will collect clinical, laboratory, imaging, and microbiological data to analyze the characteristics and treatment outcomes of these conditions. The study will also evaluate predictive factors for treatment success and mortality over time, contributing valuable insights into infectious disease management.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with clinically suspected or microbiologically documented infectious diseases.
Not a fit: Patients who are unable to provide informed consent and do not have a legal representative may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding and treatment of infectious diseases, leading to improved patient outcomes.
How similar studies have performed: Other studies focusing on infectious disease registries have shown success in improving treatment protocols and patient outcomes, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with clinically suspected or microbiologically documented infectious diseases (bacterial, viral, fungal or parasitic); * At least 18 years of age or older; * Able to provide informed consent; * Participants who are unable to understand the study protocol or are unable to give informed consent, but have a legal representative Exclusion Criteria: \- Participants who are unable to understand the study protocol or are unable to give informed consent, and have no legal representative.
Where this trial is running
Milan
- San Raffaele Scientific Institute — Milan, Italy (Recruiting)
Study contacts
- Principal investigator: Marco Ripa, MD — IRCCS San Raffaele Scientific Institute
- Study coordinator: Elisabetta Carini
- Email: carini.elisabetta@hsr.it
- Phone: +390226437934
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.